“We want to do our part to help patients living with COPD or asthma who struggle to pay for their medications. This new program supports patients with predictable, affordable costs at the ...

Third-year students Hannah Wiseman (Med ’26) and Krishny Karunanandaa (Med ’26) experienced this firsthand as they helped address a community need: approved access to inhalers for asthma and allergy ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

Researchers are looking at ways to boost the performance and lower the environmental impact of millions of inhalers used for treating asthma and COPD. Working with drug manufacturer Kindeva, ...

AstraZeneca recently announced the completion of clinical studies for a next-generation propellant (NGP) version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new ...

A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung diseases such as emphysema. The main cause is smoking, although the ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Medscape Medical News, October 04, 2024 Alert FDA Approves Dupilumab as Add-On for COPD Injectable biologic was approved as adjuvant therapy to inhaled medications. Medscape Medical News ...

Medications alone should not ... is often a great way to start exercising if you have COPD. Resistance band training is also ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...